Description

This Genetic Technology TOE depicts trends across prebiotic and probiotic therapies for disorders of the gastrointestinal tract. The corresponding analysis of leading prebiotic and probiotic companies, and the analysis of Top 20 companies with OTC prebiotics and probiotics are depicted along with industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Prebiotic therapies, probiotic therapies, gastrointestinal tract, lactose intolerance, inflammatory bowel disease, diarrhea management, yeasts, intestinal health